Vaccine Production Differences
A discussion reveals that the Pfizer vaccine produced in the U.S. differed from that in Europe, raising questions about the implications of separate production lines. Despite significant findings published in a study, Pfizer has remained silent, prompting concerns about transparency and regulatory scrutiny from health authorities in the UK and Europe. The lack of response from Pfizer suggests potential issues with the vaccine's formulation that warrant further investigation.In this clip
From this podcast
Doc Malik
I Discuss "Bad Batches" With Dr Vibeke Manniche
Related Questions